Results 111 to 120 of about 136,379 (287)
Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer
Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan +3 more
wiley +1 more source
Immunoexpression of TTF-1 in Non-Lung Tumors
Bezmiâlem Science, 2014 Objective:Thyroid transcription factor-1 (TTF-1) immunoexpression is frequently determined in small-cell lung carcinomas, as well as primary lung adenocarcinomas. While dealing with metastatic carcinomas, TTF-1 immunoexpression is a significant indicator
Zeynep TOSUNER +5 more
doaj +1 more source
A case of renal cell carcinoma found through skin metastasis in a dog
Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.Abstract A French bulldog presenting with a skin mass was found to have an enlarged left kidney on a preoperative systemic examination. The left kidney and skin mass were surgically removed. Histopathological and immunohistochemical analyses identified the enlarged left kidney as renal cell carcinoma, with the skin mass likely representing a metastatic
Seisuke Murashima +2 more
wiley +1 more source
Severe anaemia secondary to duodenal adenoma in a cat
Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.Abstract A 7‐year‐old female, spayed, domestic shorthair presented with a 24‐hour history of anorexia, lethargy and melaena. The cat was hospitalized and received treatment for hypovolemia, various electrolyte abnormalities and severe anaemia with a blood transfusion, intravenous fluids and medications.
Jocosa Yasenchack +4 more
wiley +1 more source
Non‐surgical management vs active treatment in T1a renal cell carcinoma: a population‐based study
BJU International, Volume 137, Issue 2, Page 297-305, February 2026.Objectives To compare overall and cancer‐specific survival for clinical (c)T1aN0M0 renal cell carcinoma (RCC) in patients treated with non‐surgical management (NSM: surveillance and watchful waiting) or active treatment (surgery and ablative treatments). Patients and methods In this nationwide real‐world population‐based cohort study, data on clinical,
Bassam Mazin Hashim +4 more
wiley +1 more source
BMC CancerPANoptosis is a specific type of inflammatory programmed cell death (PCD) modality that can be involved in three key modes of cellular programmed cell death-pyroptosis, apoptosis and necroptosis. We analyzed PANoptosis activity in three common renal cell
Yan Xu +6 more
doaj +1 more source
Lymph node ratio has greater prognostic value than positive lymph node count in papillary renal cell carcinoma [PDF]
, 2023 Lun Zhao +7 more
openalex +1 more source